Verrica Pharmaceuticals (VRCA) Receivables (2022 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Receivables of $7.7 million for Q1 2026, up 36.64% year-over-year from $5.7 million in Q1 2025, and up 46.84% quarter-over-quarter from $5.3 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Receivables (2022 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Receivables history runs 5 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Receivables rose 36.64% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (up 36.64% YoY), while the FY2025 annual figure was $5.3 million, up 6731.17% from the prior year.
- Receivables for Q1 2026 stood at $7.7 million, up from $5.3 million in the prior quarter.
- The five-year high for Receivables was $10.2 million in Q2 2024, with the low at $77000.0 in Q4 2024.
- The 5-year median for Receivables is $5.5 million (2025), against an average of $5.1 million.
- The sharpest annual moves came in 2024 and 2025: Receivables sank 98.26% in 2024, then soared 8289.29% in 2025.
- Verrica Pharmaceuticals' Receivables stood at $99000.0 in 2022, then soared by 4360.61% to $4.4 million in 2023, then tumbled by 98.26% to $77000.0 in 2024, then jumped by 6731.17% to $5.3 million in 2025, then soared by 46.84% to $7.7 million in 2026.
- Business Quant data shows VRCA's Receivables at $7.7 million in Q1 2026, $5.3 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | - |
| 10 | Verrica Pharmaceuticals | 105.87 Mn | 94.67 Mn | - | 13.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.24 Mn |
| Mar 31, 2026 | 7.72 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 10.18 Mn |
| Mar 31, 2024 | 7.59 Mn |
| Dec 31, 2023 | 4.42 Mn |
| Sep 30, 2023 | 4.07 Mn |
| Dec 31, 2022 | 99,000.00 |